NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025

Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson, Muhamed Baljevic, Rachid Baz, Erica Campagnaro, Caitlin Costello, Christopher D'Angelo, Benjamin Derman, Srinivas Devarakonda, Noura Elsedawy, Amandeep Godara, Kelly Godby, Jens Hillengass, Leona Holmberg, Myo Htut, Carol Ann Huff, Malin Hultcrantz, Yubin KangSarah Larson, Hans C Lee, Michaela Liedtke, Thomas Martin, James Omel, Timothy Robinson, Aaron Rosenberg, Mark A Schroeder, Daniel Sherbenou, Attaya Suvannasankha, Jason Valent, Asya Nina Varshavsky-Yanovsky, Dan Vogl, Emily Kovach, Rashmi Kumar

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The NCCN Guidelines for Multiple Myeloma (MM) provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with MM. These NCCN Guidelines Insights highlight the important updates and changes specific to systemic therapy for patients with newly diagnosed as well as previously treated MM included in Version 1.2025 of the NCCN Guidelines for MM.

Original languageEnglish
Pages (from-to)132-140
Number of pages9
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume23
Issue number5
DOIs
StatePublished - May 2025

Keywords

  • Humans
  • Multiple Myeloma/diagnosis
  • Medical Oncology/standards

Fingerprint

Dive into the research topics of 'NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025'. Together they form a unique fingerprint.

Cite this